Funding for this research was provided by:
National Cancer Institute (R01CA188892)
National Institute of Diabetes and Digestive and Kidney Diseases (T32DK083250)
Received: 4 June 2019
Accepted: 10 June 2020
First Online: 16 June 2020
Ethics approval and consent to participate
: This trial was approved by the HealthPartners Institute Institutional Review Board on December 22, 2014 (application number A13-012). All participants will provide written informed consent prior to participation in the study to one of the research team members.
: Not applicable.
: The authors declare that they have no competing interests.